|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-1-24
|
|
pubmed:abstractText |
Common treatment practices in patients who continue to be symptomatic on proton pump inhibitor once-daily treatment include either increasing the dosage or the use of supplemental medication. This trial's purpose was to compare 2 therapeutic strategies, increasing the proton pump inhibitor dosage to twice daily versus switching to another proton pump inhibitor, in patients with persistent heartburn while receiving standard-dose proton pump inhibitor therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1542-3565
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
50-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16431305-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:16431305-Adult,
pubmed-meshheading:16431305-Aged,
pubmed-meshheading:16431305-Double-Blind Method,
pubmed-meshheading:16431305-Enzyme Inhibitors,
pubmed-meshheading:16431305-Female,
pubmed-meshheading:16431305-H(+)-K(+)-Exchanging ATPase,
pubmed-meshheading:16431305-Heartburn,
pubmed-meshheading:16431305-Humans,
pubmed-meshheading:16431305-Male,
pubmed-meshheading:16431305-Middle Aged,
pubmed-meshheading:16431305-Omeprazole
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Treatment of patients with persistent heartburn symptoms: a double-blind, randomized trial.
|
|
pubmed:affiliation |
The Neuro-Enteric Clinical Research Group, Department of Medicine, Section of Gastroenterology, Southern Arizona VA Health Care System and University of Arizona Health Sciences Center, Tucson 85723-0001, USA. Ronnie.Fass@med.VA.gov
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
